Department Orthopaedic Surgery, Keck School of Medicine, University of Southern California, 1450 San Pablo St, HC4 - #5400A, Los Angeles, CA, 90033, USA.
Eur Spine J. 2021 May;30(5):1329-1336. doi: 10.1007/s00586-020-06706-y. Epub 2021 Jan 4.
To elucidate the effects of bisphosphonates on complications following posterior lumbar fusion (PLF) with a large database study.
The PearlDiver Patient Record Database was queried to identify adult patients who had undergone posterior lumbar fusion (PLF). Those patient cohorts were divided based on a diagnosis of osteoporosis prior to surgery and bisphosphonate usage. This yielded three groups: Osteo+Bisph+, Osteo+Bisph-, and Osteo-Bisph-. The primary outcome of the present study was revision rates at 6 months and 1 year following surgery. Incidence of postoperative complications was analyzed, and statistical analysis was conducted using Pearson chi-square analysis.
Patients taking bisphosphonates did not have significantly different rates of revision surgery at 6 months and 1 year, instrumentation complications, or post-vertebral fractures than patients not taking bisphosphonates. Additionally, osteoporotic patients did not have significantly different rates of these complications than patients without osteoporosis.
Bisphosphonate usage did not significantly affect the rates of postoperative complications following posterior lumbar fusion. Further research is required to fully elucidate the effects of bisphosphonates on outcomes and complications following spine surgery.
利用大型数据库研究阐明双磷酸盐对腰椎后路融合(PLF)后并发症的影响。
在 PearlDiver 患者记录数据库中查询接受腰椎后路融合(PLF)的成年患者。根据手术前骨质疏松症和双磷酸盐使用情况对这些患者队列进行分组。这产生了三组:Osteo+Bisph+、Osteo+Bisph-和 Osteo-Bisph-。本研究的主要结果是术后 6 个月和 1 年的翻修率。分析术后并发症的发生率,并使用 Pearson 卡方分析进行统计学分析。
服用双磷酸盐的患者在 6 个月和 1 年时的翻修手术、器械并发症或椎骨后骨折的发生率与未服用双磷酸盐的患者没有显著差异。此外,骨质疏松症患者的这些并发症发生率与无骨质疏松症患者没有显著差异。
双磷酸盐的使用并未显著影响腰椎后路融合术后并发症的发生率。需要进一步研究以充分阐明双磷酸盐对脊柱手术后结果和并发症的影响。